LabCorp will be acquiring MEDTOX in a premium buyout that values the company at a share price not seen since briefly in 2007. The purchase price is at $27.00 per share and the merger is an all cash deal. It will also give MEDTOX A total enterprise value of approximately $241,000,000 after considering equity and debt.
MEDTOX is a provider of high quality specialized lab testing services and on-site/point-of-collection testing devices. The board of directors of MEDTOX unanimously approved the agreement and recommended approval of the transaction by MEDTOX’s shareholders.
Shares are up 35% at $26.71 for MEDTOX versus a prior 52-week trading range of $11.64 to $22.55; Laboratory Corp. of America Holdings (NYSE: LH) shares are up 0.9% at $83.07 against a 52-week range of $74.57 to $99.76. As far as how the value compares, LabCorp has a market value of some $8 billion.
JON C. OGG
Top Gaining Stocks
Top Losing Stocks